You have no items in your shopping cart.
Human IL-2RA [orb2994463]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 48.9 KDa. Observed: 60-80 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human IL-2RA [orb2994464]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 35-44 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Mouse IL-2RB [orb2993765]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 26.1 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Mouse IL-2RB [orb2993766]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 52.2 KDa. Observed: 70-110 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Cynomolgus IL-2RA [orb2992803]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 48.6 KDa. Observed: 65-75 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human IL-2RA [orb2992878]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 24.6 KDa. Observed: 33-55 KDa, reducing conditions
100 μg, 20 μg - Cynomolgus IL-2RA [orb2992887]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 22.5 KDa. Observed: 28-48 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human IL-2 R beta&IL-2 R gamma Heterodimer [orb2992889]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 54&51 KDa. Observed: (57-72)&(85-115) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 51.4&75.7 KDa. Observed: 54-66&98-140 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Item 1 of 1
